Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials.

Diane Thiboutot, Leon Kircik, Amy McMichael, Fran Cook-Bolden, Stephen K. Tyring, David R. Berk, Joan-En Chang-Lin, Vince Lin, Alexandre Kaoukhov

PubMed · 2016 · 17 citations · 12 references

Concepts

Abstract

Dapsone gel, 7.5%, with a 50-percent greater dapsone concentration than twice-daily dapsone gel, 5% formulation, is applied topically once daily for acne, is effective, safe, and well-tolerated over 12 weeks, and has local tolerability similar to that of vehicle. www.clinicaltrials.gov identifiers: NCT01974141 and NCT01974323.

References

12